BactiBlock against Multidrug-Resistant Bacteria

According to the World Health Organization (WHO), antibiotic resistance is rising to dangerously high levels in all parts of the world. New resistance mechanisms are emerging and spreading globally, threatening our ability to treat common infectious diseases.

Antimicrobial Resistance (AMR) occurs when bacteria, viruses, fungi and parasites change over time and no longer respond to medicines or other antimicrobial products, making infections harder to treat and increasing the risk of disease spread, severe illness and death. As a result of drug resistance, antibiotics and other antimicrobial products become ineffective and infections become increasingly difficult or impossible to treat.

Taking this into consideration, studying BactiBlock capabilities against multi-drug resistance bacteria seemed something definitively necessary. Hence, specific tests have been carried out at an external laboratory with the aim of showing such kind of activity for BactiBlock 920 B4 and BactiBlock 101 R4.47.

The list of microorganisms has been chosen considering the WHO criteria and priorities established by them:

Priority 1: CRITICAL

Acinetobacter baumannii, carbapenem-resistant (Acinetobacter baumannii NCTC 13302)
Pseudomonas aeruginosa, carbapenem-resistant (Pseudomonas aeruginosa NCTC 13437)
Enterobacteriaceae, carbapenem-resistant, ESBL-producing (Escherichia coli NCTC 13353, Salmonella CIP 107220)

Priority 2: HIGH

Enterococcus faecium, vancomycin-resistant (Enterococcus faecium CECT 5253)
Staphylococcus aureus, methicillin-resistant, (Staphylococcus aureus CECT 5190)

Priority 3: MEDIUM

Streptococcus pneumoniae, penicillin-non-susceptible (Streptococcus pneumoniae CIP 10447

Results confirmed that in all cases and at usual addition levels, BactiBlock 920 B4 and BactiBlock 101 R4.47, thanks to its silver antimicrobial technology, are still highly effective. Since these critical microorganisms don’t have effective treatment at the moment, the effectiveness of BactiBlock against them can be considered has a highly promising result.

Previous news

How should I market my BactiBlock®-enhaced product?

In today's health-conscious world, especially after the coronavirus pandemic, running a marketing campaign that promotes the antimicrobial properties of a product represents a unique opportunity for manufacturers to stand out from competitors and bring significant...

Why biocides are worth using?

Biocides are needed to solve problems in a large number of different environments. Some products are used to protect humans or animals, in other cases, an industrial process needs to be protected. Wherever there is moisture and a potential food source, we will find as...

BactiBlock® in PVC applications

PVC, also known as Polyvinyl chloride, is one of the most widely used plastics in the world with a broad range of long-life applications. Ideal for everything from construction, to healthcare, electronics, and tons of other applications, the use of PVC is incredibly...

BactiBlock® will exhibit in Dubai at the UTECH MEFPU Expo 2023

After the first edition held in June 2022, this year UTECH - Middle East Foam & Polyurethane Expo returns from September 5th to 7th, and BactiBlock® will be there! UTECH MEFPU Expo is the most important event in the Middle East region dedicated to the foam and...

BactiBlock® will be in FOAM EXPO NORTH AMERICA !

Foam Expo North America, the world's largest dedicated foam technology exhibition and conference, will once again be held in Novi, Michigan. And BactiBlock antimicrobial additives will be there! The Show will be held from June 20 to 22 in Michigan. A region that has...